StockData

Braskem vs Methanex

BAK and MEOH side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How BAK and MEOH compare

Methanex grew revenue faster over the last twelve months (−3.5% versus −8.6% for Braskem).

Methanex scores higher on the StockData Score (4 against 1 for Braskem), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricBAKMEOH
Size and price
Share price$0.890$67.03
Change, 1 year−70.8%82.2%
Change, 5 years−95.1%58.9%
Beta (5Y)0.97−0.86
Employees1,809–
StockData Score
Total score14 (better)
Valuation score00
Growth score01 (better)
Performance score1 (better)0
Health score03 (better)
Dividend score00
Growth
Revenue growth (TTM)−8.6%−3.5% (better)
Revenue growth, 5Y average3.9%6.3% (better)
EPS growth (TTM)–−61.1%
Profitability
Gross margin2.2%35.7% (better)
Operating margin−2.6%12.0% (better)
Net margin−14.0%–
FCF margin−10.3%25.5% (better)
Return on invested capital−4.4%7.3% (better)
Financial health
Debt / equity–1.13
Net debt / EBITDA12.162.65 (better)
Interest coverage−0.3×2.0× (better)
Current ratio0.762.06 (better)
Piotroski F-score2–
Dividends and buybacks
Years of dividend growth–1
Dividend growth, 5Y average–9.4%
Ownership
Held by institutions4.1%76.2%
Held by insiders3.2%15.3%
Superinvestors holding–1
Short interest, % of float–3.7%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.